Skip to main content

Our Clients

We have worked with over 2000 companies, investors and research institutions.

All clients, by client group

  • Alliance Foundation Trials, LLC
  • Bluefield Project to Cure FTD
  • Cure GM1 Foundation
  • FB2 Services (Florida Biologix)
  • Global Alliance for TB Drug Development
  • Ibis Reproductive Health
  • Massachusetts Eye and Ear
  • Open Philanthropy LLC
  • Partners In Health
  • The Center for Discovery
Learn more about our work in this industry

  • AB Biosciences, Inc.
  • Ambulomics, Inc.
  • Arcaea, LLC
  • Articulate Labs, Inc.
  • Bitome, Inc.
  • Covid Rapid AB Test, LLC
  • Covid Rapid Test - Texas, LLC
  • Custom Automated Prosthetics
  • Day Zero Diagnostics, Inc.
  • Dialco Medical Inc.
  • Digital Cognition Technologies, Inc.
  • Digital Cognition Technologies, Inc.
  • Discovery Life Sciences, LLC
  • GelMEDIX, Inc.
  • hearX Group (Pty) Ltd.
  • HighRes Biosolutions, Inc.
  • Instylla, Inc.
  • Occlutech International AB
  • Omada Health, Inc.
  • Palette Life Sciences AB
  • PhosImmune
  • Presympto, Inc.
  • Savran Technologies Inc.
  • Sirtex Technology Pty Ltd
  • Spectral Medical Inc.
  • Techcomp (Holdings) Limited
  • Tides Medical LLC
  • Vizgen, Inc.
Learn more about our work in this industry

  • Abata Therapeutics, Inc.
  • Actithera, Inc.
  • Adrenas Therapeutics, Inc.
  • AesRx
  • Affini-T Therapeutics, Inc.
  • Affinia Therapeutics, Inc.
  • Affinivax, Inc.
  • Agenus, Inc.
  • Akouos, Inc.
  • Aldeyra Therapeutics, Inc.
  • Aliada Therapeutics, Inc.
  • Allorion Therapeutics Inc.
  • Allyx Therapeutics, Inc.
  • Alpheus Medical, Inc.
  • Altum Pharmaceuticals Inc.
  • AmbAgon Therapeutics, Inc.
  • Ananda Scientific, Inc.
  • Anebulo Pharmaceuticals, Inc.
  • Annapurna Therapeutics
  • Anokion US, Inc.
  • Anthos Therapeutics, Inc.
  • AnTolRx, Inc.
  • Apic Bio, Inc.
  • Arbor Biotechnologies, Inc.
  • ARKUDA Therapeutics, Inc.
  • Arrakis Therapeutics, Inc.
  • Arsanis Therapeutics
  • Artax Biopharma, Inc.
  • Artivus Therapeutics, Inc.
  • AS2 Bio, LLC
  • Ascendant Biotech Corporation
  • AsclepiX Therapeutics, Inc.
  • Aspa Therapeutics, Inc.
  • Astria Therapeutics, Inc.
  • Atara Biotherapeutics
  • Atavistik Bio
  • aTyr Pharma, Inc.
  • Aura Biosciences, Inc.
  • Auron Therapeutics, Inc.
  • Auxolytic, Ltd.
  • AvenCell Therapeutics, Inc.
  • Avenge Bio, Inc.
  • Axial Therapeutics, Inc.
  • Beam Therapeutics, Inc.
  • BeiGene, Ltd.
  • Bicara Therapeutics Inc.
  • BioSynapse, Inc.
  • Black Diamond Therapeutics, Inc.
  • Blue Oak Pharmaceuticals, Inc.
  • Bridge Biotherapeutics Inc.
  • BridgeBio Pharma
  • Carbon Biosciences, Inc.
  • Catamaran Bio, Inc.
  • Cedilla Therapeutics, Inc.
  • CG Pharmaceuticals, Inc.
  • Chinook Therapeutics, Inc.
  • Cimeio Therapeutics AG
  • Claris Biotherapeutics, Inc.
  • Clear Creek Bio, Inc.
  • Clover Key Bioscience, Inc.
  • Cogent Biosciences, Inc.
  • Cora Biosciences, Inc.
  • Corbus Pharmaceuticals Inc.
  • Corner Therapeutics, Inc.
  • Crimson BioPharm Inc.
  • Curie Therapeutics, Inc.
  • Curileum Discovery Ltd
  • Cybrexa, Inc.
  • Cyteir Therapeutics, Inc.
  • DEM BioPharma, Inc.
  • DermBiont, Inc.
  • Dianthus Therapeutics, Inc.
  • Diceros Therapeutics, Inc.
  • Dyne Therapeutics, Inc.
  • Editas Medicine, Inc.
  • Eicosis LLC
  • Elevian, Inc.
  • Elicio Therapeutics, Inc.
  • Emugen Therapeutics, Inc.
  • Enzyme By Design, Inc.
  • Epalex Corporation
  • Epibiologics, Inc.
  • EpimAb Biotherapeutics Inc.
  • Ernest Pharmaceuticals, LLC
  • Eumentis Therapeutics, Inc.
  • EvolveImmune Therapeutics, Inc.
  • Expansion Therapeutics, Inc.
  • F-star Delta Limited
  • Finch Therapeutics, Inc.
  • Flame Biosciences, Inc.
  • Flare Therapeutics
  • FOG Pharmaceuticals, Inc.
  • Forma Therapeutics, Inc.
  • Fulcrum Therapeutics, Inc.
  • Fusion Pharmaceuticals, Inc.
  • General Oncology, Inc.
  • Generate Biomedicines
  • GV.M1 Inc.
  • GV20 Therapeutics LLC
  • H3 Biomedicine
  • Hatch Therapeutics, Inc.
  • hC Bioscience, Inc.
  • HilleVax, Inc
  • Holobiome, Inc.
  • HotSpot Therapeutics, Inc.
  • Huya Bioscience International, LLC
  • IDBiologics, Inc.
  • IDEAYA Biosciences, Inc.
  • Ikena Oncology, Inc.
  • Imara, Inc.
  • ImmunoGen, Inc.
  • Infinity Pharmaceuticals, Inc.
  • InflaRx GmbH
  • Inozyme Pharma Inc.
  • INSTA Therapeutics, Inc.
  • Intellia Therapeutics, Inc.
  • Intergalactic Therapeutics, Inc
  • iOmx Therapeutics AG
  • Ipsen Bioscience Inc.
  • iTeos Therapeutics, Inc.
  • Jounce Therapeutics, Inc.
  • KalVista Pharmaceuticals, Inc.
  • Kantum Pharma, Inc.
  • Kanyos Bio, Inc.
  • Keros Therapeutics, Inc.
  • Kezar Life Sciences, Inc.
  • Kirilys Therapeutics, Inc.
  • Kite Pharma, Inc.
  • Kojin Therapeutics, Inc.
  • KSQ Therapeutics, Inc.
  • Kymera Therapeutics, Inc.
  • Laronde
  • Lexeo Therapeutics, Inc.
  • Lyra Therapeutics, Inc.
  • Lysosomal Therapeutics, Inc.
  • Magnet Biomedicine, Inc.
  • MarPam Pharma, LLC
  • Matchpoint Therapeutics, Inc.
  • MediBeacon Inc.
  • Merlin Therapeutics, Inc.
  • Mnemo Therapeutics SAS
  • Molecular Skin Therapeutics, Inc.
  • Molecular Templates, Inc.
  • Moment Bio, Inc.
  • MorphoSys AG
  • Myeloid Therapeutics, Inc.
  • Mythic Therapeutics, Inc.
  • Neomorph, Inc.
  • Neurogastrx, Inc.
  • NextPoint Therapeutics, Inc.
  • NiKang Therapeutics, Inc.
  • Nocion Therapeutics, Inc.
  • Normunity AccelCo, Inc.
  • Normunity, Inc.
  • Nurix Therapeutics, Inc.
  • Obsidian Therapeutics, Inc.
  • Okava Pharmaceuticals, Inc.
  • Olaris Inc.
  • Oligomerix, Inc.
  • Omega Therapeutics, Inc.
  • Oncorus, Inc.
  • ONK Therapeutics Limited
  • Orna Therapeutics, Inc.
  • Ossianix, Inc.
  • Otter Immuno-oncology, LLC
  • PanOptica, Inc.
  • Paragon Therapeutics, Inc.
  • Paratus Sciences Corporation
  • Parthenon Therapeutics, Inc.
  • Pathalys Pharma, Inc.
  • Peptilogics, Inc.
  • perForm biologics, inc.
  • Phenex Pharmaceuticals AG
  • Phoenix Tissue Repair, Inc.
  • Photys, Inc.
  • Phylaxis Bioscience, LLC
  • PIC Therapeutics, Inc.
  • Pinetree Therapeutics, Inc.
  • Polymed Biopharmaceuticals, Inc.
  • Promedior, Inc.
  • ProThera Biologics, Inc.
  • Pyxis Oncology, Inc.
  • Q1, Inc.
  • QurAlis Corporation
  • QurAlis Corporation
  • Regenacy Pharmaceuticals, Inc.
  • Rekindle Therapeutics Inc.
  • Relay Therapeutics, Inc.
  • Repare Therapeutics, Inc.
  • resTORbio, Inc.
  • Revalia Bio, Inc.
  • Rheos Medicines, Inc.
  • Rhoshan Pharmaceuticals, Inc.
  • Ridgeline Discovery GmbH
  • Right Brain Bio, Inc.
  • Rila Therapeutics, Inc.
  • Rizana Therapeutics, Inc.
  • Rubius Therapeutics, Inc.
  • SalioGen Therapeutics, Inc.
  • Schrödinger, Inc.
  • Scorpion Therapeutics, Inc.
  • Seal Rock Therapeutics, Inc.
  • Sentien Biotechnologies, Inc.
  • Shenzhen Pharmacin Co., Ltd.
  • Sieben Therapeutics, Inc.
  • Simcha IL-18, Inc.
  • Sionna Therapeutics, Inc.
  • Sojournix, Inc.
  • SonALAsense, Inc.
  • Sonnet BioTherapeutics, Inc.
  • Sorrento Therapeutics, Inc.
  • SOTIO Biotech Inc.
  • Souffle Therapeutics
  • Spruce Biosciences, Inc.
  • STORM Therapeutics Ltd.
  • Strand Therapeutics, Inc.
  • Summation Bio, Inc.
  • Surface Oncology, Inc.
  • SURGE Therapeutics, Inc.
  • Syndax Pharmaceuticals, Inc.
  • Synedgen, Inc.
  • Syros Pharmaceuticals, Inc.
  • T-knife Therapeutics, Inc.
  • Tasca Therapeutics Corp.
  • Tavanta Therapeutics, Inc.
  • Tectonic Therapeutic, Inc.
  • Teneobio, Inc.
  • Tessera Therapeutics, Inc.
  • Test 6
  • Theaprin Pharmaceuticals, Inc.
  • Theragnostics Ltd.
  • Third Harmonic Bio, Inc.
  • Totus Medicines Inc.
  • TransformaTX Biotherapeutics LLC
  • Transition Bio, Inc.
  • Treadwell Therapeutics, Inc.
  • Triplet Therapeutics, Inc.
  • Vedere Bio, Inc.
  • Vernal Biosciences, Inc.
  • Verra Therapeutics, LLC
  • Versatope Therapeutics, Inc.
  • Verseau Therapeutics, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Vertical Bio AG
  • Verve Therapeutics, Inc.
  • Viridian Therapeutics, Inc.
  • Viridian, LLC
  • Volastra Therapeutics, Inc.
  • Wade Biomedicines Inc.
  • Walking Fish Therapeutics, Inc.
  • WAVE Life Sciences Ltd.
  • Xbiome, Inc.
  • Xellar, Inc.
  • XenImmune Therapeutics, Inc.
  • Yumanity Therapeutics
  • Yumanity Therapeutics
  • Zenon Biotech, Inc.
Learn more about our work in this industry

  • 143 Digital, LLC
  • Advanced Development Methods, Inc.
  • Artha Networks, Inc.
  • Codiscope, LLC
  • Curated Planet, LLC
  • Dexai Robotics, Inc
  • Drishti Technologies, Inc.
  • Gleason Technology, Inc.
  • GlobalSign, Inc.
  • IQ Proteomics, LLC
  • Liteboxer Technologies, Inc.
  • Mel Robbins Productions, Inc.
  • Muzooka, Inc.
  • Optera Life Sciences, LLC
  • Sibyl Analytics, LLC
  • YBRP, Inc.
  • Zone Motion, LLC
Learn more about our work in this industry

  • .406 Ventures
  • 4D Molecular Therapeutics, Inc.
  • 5AM Venture Management LLC
  • 6 Dimensions Capital
  • AllerFund Ventures, LLC
  • Arch Venture Fund XII
  • Atlas Venture
  • CBT Advisors
  • CoVenture
  • Cure Ventures Management, L.P.
  • Epidarex Management, Ltd.
  • Flagship Pioneering
  • GG1978 SICAF SIF
  • Gimv NV
  • GV Management Company, LLC
  • Hutchison MediPharma Limited
  • Lundbeckfond Ventures
  • Novo Ventures
  • Ross Equity Partners, L.P.
  • Sann Opportunity Zone, LLC
  • Soffer Holdings LLC
  • Test 3
  • Test 4
  • Test 5
  • Test Client 2
  • U.S. Equity Holdings, LLC
  • Versant Ventures Management, LLC
Learn more about our work in this industry

Recent transactions

Previous Page
Next Page
6 Dimensions Capital Logo

6 Dimensions Capital

VC Investments

Equity investments in multiple portfolio companies, including Hibercell

Puma Biotechnology, Inc. Logo

Puma Biotechnology, Inc.

Clinical Trial

CRO and Site Agreements for an Open-Label, Phase 2 Study with 30 Sites in 9 Countries exploring the efficiency of Neratinib on Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations Or EGFR Gene Amplification

See Study
Vizgen, Inc. Logo

Vizgen, Inc.

Series C Financing

Vizgen raises Series C equity funding led by Blue Water Life Science Advisors, LLC, ARCH Venture Fund X, L.P. and other existing investors

Press Release
Vernal Biosciences, Inc. Logo

Vernal Biosciences, Inc.

Series A Financing

Vernal Biosciences raises $21M Series A equity funding led by Dynamk Life Sciences Fund, L.P., Charles River Laboratories, Inc. and Ampersand 2020 Limited Partnership

Press Release
Artax Biopharma, Inc. Logo

Artax Biopharma, Inc. + Advent Life Sciences Fund II LP

Series B Financing (Series B4)

Artax Biopharma raises Series B-4 round of equity funding led by Advent Life Sciences Fund II LP, Advent Life Sciences LLP, Columbus Life Science Fund II, FCR, Hiyuli Ventures Limited, Belinda A. Termeer, and other existing investors, plus new investors including Sound Bioventures Fund I AB and and Eli Lilly

Press Release
Dianthus Therapeutics, Inc. Logo

Dianthus Therapeutics, Inc.

Series A Financing

Dianthis raises $100 million Series A financing led by 5AM Ventures, Fidelity Management & Research Company, Avidity Partners, Venrock, Fairmount Funds, Tellus BioVentures and other investors

Press Release
Summation Bio, Inc. Logo

Summation Bio, Inc.

Series A Financing

Summation Bio raises Series A equity funding led by RA Capital Healthcare Fund, L.P., RA Capital NEXUS Fund, L.P., RA Capital NEXUS Fund III, L.P., Blackwell Partners LLC and other existing investors

ONK Therapeutics Limited Logo

ONK Therapeutics Limited + Intellia Therapeutics, Inc.

License, Collaboration and Option Agreement

License, Collaboration and Option Agreement to advance allogeneic CRISPR-Edited NK cell therapies, with milestones up to $920M per product plus royalties

Press Release
DermBiont, Inc. Logo

DermBiont, Inc. + Chromaderm, Inc.

Private Company Acquisition

DermBiont acquires Chromaderm, Inc.

Press Release
Sirtex Technology Pty Ltd Logo

Sirtex Technology Pty Ltd

Clinical Trial

CRO and Site Agreements for a pivotal device study with 15 US sites to evaluate the safety and effectiveness of SIRT using SIR-Spheres Y-90 resin microspheres as first-line treatment for local control of HCC (Barcelona clinic liver cancer (BCLC) stage A, BCLC stage B1 and BCLC stage B2)

See Study
IDEAYA Biosciences, Inc. Logo

IDEAYA Biosciences, Inc.

Clinical Trial

CRO and Site Agreements for a Phase I Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses of IDE397 (MAT2A inhibitor) in patients with advanced solid tumors

See Study
Vizgen, Inc. Logo

Vizgen, Inc.

Series B Financing

Vizgen raises Series B equity funding from Northpond Ventures LP, ARCH Venture Fund X, L.P., Novalis LifeSciences LLC, Tao Capital Management, Pura Vida Investments and other current investors

Press Release

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.